| Literature DB >> 29505193 |
Christoph U Correll1,2, John Lauriello3.
Abstract
Long-acting injectable (LAI) antipsychotics have the potential to improve adherence and outcomes for patients with serious mental illness but are underused. Watch this Webcast to learn how to identify patients who may benefit from using LAIs, monitor treatment adherence, and use LAIs safely and effectively in patients with schizophrenia and related disorders. © Copyright 2018 Physicians Postgraduate Press, Inc.Entities:
Mesh:
Substances:
Year: 2018 PMID: 29505193 DOI: 10.4088/JCP.AL17017WC1C
Source DB: PubMed Journal: J Clin Psychiatry ISSN: 0160-6689 Impact factor: 4.384